Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)

Elanco Animal Health has disclosed Cash from Investing Activities across 10 years of filings, most recently posting -$110.0 million for Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 96.43% year-over-year to -$110.0 million; the TTM figure through Jun 2026 stood at -$335.0 million (down 132.21% YoY), while the FY2025 annual figure was -$279.0 million, down 124.09% from the prior year.
• Cash from Investing Activities came in at -$110.0 million for Q2 2026 at Elanco Animal Health, down from -$60.0 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $1.2 billion in Q3 2024 to a low of -$110.0 million in Q2 2026.
• Average Cash from Investing Activities over 5 years is $20.1 million, with a median of -$49.0 million recorded in 2023.
• Year-over-year, Cash from Investing Activities sank 390.0% in 2022 and jumped 3555.56% in 2024.
• Over 5 years, Cash from Investing Activities stood at -$76.0 million in 2022, then jumped by 53.95% to -$35.0 million in 2023, then plunged by 157.14% to -$90.0 million in 2024, then rose by 28.89% to -$64.0 million in 2025, then slumped by 71.88% to -$110.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$110.0 million in Q2 2026, -$60.0 million in Q1 2026, and -$64.0 million in Q4 2025.